0LI: 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzam
ide
0LI is a Ligand Of Interest in 3IK3 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
3IK3_0LI_A_1 | 44% | 32% | 0.152 | 0.877 | 1.78 | 0.93 | 9 | - | 0 | 0 | 100% | 1 |
3IK3_0LI_B_2 | 43% | 31% | 0.155 | 0.877 | 1.86 | 0.92 | 12 | - | 0 | 0 | 100% | 1 |
3OXZ_0LI_A_1 | 57% | 29% | 0.159 | 0.936 | 1.86 | 1.01 | 11 | 3 | 1 | 0 | 100% | 1 |
6P3D_0LI_A_1001 | 88% | 16% | 0.098 | 0.973 | 2.03 | 1.66 | 6 | 11 | 0 | 0 | 100% | 1 |
7WF5_0LI_A_601 | 84% | 26% | 0.085 | 0.948 | 1.54 | 1.46 | 7 | 5 | 1 | 0 | 100% | 1 |
4U0I_0LI_A_1001 | 83% | 15% | 0.103 | 0.96 | 2.57 | 1.26 | 18 | 5 | 2 | 0 | 100% | 1 |
6TU9_0LI_A_801 | 82% | 74% | 0.11 | 0.965 | 0.31 | 0.69 | - | 1 | 1 | 0 | 100% | 1 |
3ZOS_0LI_A_1000 | 82% | 31% | 0.087 | 0.941 | 1.37 | 1.38 | 4 | 6 | 0 | 0 | 100% | 1 |